Invasive candidiasis in critically ill patients: Does progressing knowledge improve clinical management and outcome?

Current Opinion in Critical Care

Volumn 16, Issue 5, 2010, Pages 442-444

  Marchetti, Oscar ^a   Eggimann, Philippe ^a   Calandra, Thierry ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CRITICALLY ILL PATIENT; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INFECTION PREVENTION; INVASIVE CANDIDIASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NOTE; OUTCOME ASSESSMENT; RISK FACTOR;

CANDIDIASIS, INVASIVE; CRITICAL ILLNESS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS; TREATMENT OUTCOME;

EID: 78449270669     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32833e2629     Document Type: Note

References (26)

1. Martin GS, Mannino EM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554.
2. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329.
3. Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009; 48:1695-1703.
4. Tortorano AM, KibblerC, Peman J, et al. Candidemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006; 27:359-366.
5. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial Infections in US Hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-317.
6. Marchetti O, Bille J, Fluckiger U, et al. Epidemology of candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991-2000. Clin Infect Dis 2004; 38:311-320.
7. Leroy O, Gangneus JP, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37:1612-1618.
8. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organisation for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-1821.
9. Sendid B, Tabouret M, Poirot JL, et al. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis ofsystemic candidiasis. J Clin Microbiol 1999; 37:1510-1517.
10. Prella M, Bille J, Pugnale M, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51:95-101.
11. Senn L, Robinson JO, Schmidt S, et al. 1,3-Beta-D-glucan antigenemia for earlydiagnosisofinvasive fungal infectionsin neutropenicpatients with acute leukemia. Clin Infect Dis 2008; 46:878-885.
12. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654-659.
13. McMullan R, Metwally L, Coyle PV, et al. A prospective clinical trial ofa realtime polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46:890-896.
14. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758.
15. Piarroux R, Grenouillet F, Balvay P, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004; 32:2443-2449.
16. Leon C, Ruiz-Santana S, Saavedra P, et al. EPCAN StudyGroup. Abedside scoring system ('Candida score') for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34:730-737.
17. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective developmentand validation ofaclinical prediction rulefornosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007;26:271-276.
18. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 2006; 43:25-31.
19. Labelle AJ, Micek ST, Roubinian N, Kollef MH. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008;36:2967-2972.
20. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007; 60:613-618.
21. Schuster MG, Edwards Jr JE, Sobel JD, et al. Empirical fluconazole versus placebo for intensive care unit patients. a randomized trial. Ann Intern Med 2008; 149:83-90.
22. Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989; 2:1437-1440.
23. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-1072.
24. Senn L, Eggimann P, Ksontini R, et al. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med 2009; 35:903-908.
25. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233:542-548.
26. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503-535.